Analyst
Lyric Partners
Equibles does not estimate personal net worth.
Daniel Clark is recorded as Analyst at Lyric Partners. Daniel Clark has spoken on 2 earnings calls across 2 companies, most recently for Elanco Animal Health Inc on February 24, 2026. Those appearances were for Elanco Animal Health Inc (ELAN) and Zoetis Inc. (ZTS). The companies whose calls Daniel Clark spoke on are classified in the Healthcare sector.
“Great thanks thanks so much good morning everyone um just wanted to I guess first start with Quattro um the further gains via the kinetic index that you saw in the quarter um was that sort of in line with your expectations from a couple months ago, or was that incremental upside?”
“Just wanted to circle back on some guidance you gave last quarter on double-digit growth across the Derm, Trio, and OA Payne franchises. How is that tracking at this point, and how should we kind of think about the growth of those three going forward, given all the dynamics you've laid on the call?”
Lyric Partners
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
